(Q39002181)

8 September 2017

title

Increase in IkappaB kinase alpha expression suppresses the tumor progression and improves the prognosis for nasopharyngeal carcinoma (English)

1 reference

8 September 2017

1 reference

Ling Deng

1

1 reference

8 September 2017

Yan Li

2

1 reference

8 September 2017

Ping Ai

3

1 reference

8 September 2017

Yuxin Xie

4

1 reference

8 September 2017

Hong Zhu

5

1 reference

8 September 2017

Nianyong Chen

6

1 reference

8 September 2017

publication date

21 September 2013

1 reference

8 September 2017

published in

Molecular Carcinogenesis

1 reference

8 September 2017

volume

54

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

156-165

1 reference

The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway

8 September 2017

cites work

1 reference

Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression

21 January 2018

1 reference

Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression

21 January 2018

1 reference

Limb and skin abnormalities in mice lacking IKKalpha

21 January 2018

1 reference

Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase

21 January 2018

1 reference

IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas

21 January 2018

1 reference

A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas

21 January 2018

1 reference

IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing.

21 January 2018

1 reference

Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas

21 January 2018

1 reference

The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.

21 January 2018

1 reference

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

21 January 2018

1 reference

Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively

21 January 2018

1 reference

Mouse Genetic Models Reveal Surprising Functions of IkB Kinase Alpha in Skin Development and Skin Carcinogenesis

21 January 2018

1 reference

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

21 January 2018

1 reference

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

21 January 2018

1 reference

IKK-β mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death.

21 January 2018

1 reference

Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB

21 January 2018

1 reference

IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.

21 January 2018

1 reference

The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1

21 January 2018

1 reference

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.22087

1 reference

8 September 2017

1 reference